Mary Laughlin Email & Phone Number
Vice President, Clinical Science @ Iovance Biotherapeutics, Inc.
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Mary Laughlin Location
- New Providence, NJ, US
Mary Laughlin Work
- Vice President, Clinical Science @ (June 2025 - Present)
- Medical Director, Founder @ (January 2007 - Present)
- Vice President, Head of Global Late Stage Clinical Development @ (January 2024 - June 2025)
- Vice President, Global Program Head, Oncology @ (August 2022 - January 2024)
- Vice President, World-Wide Hematology, Cell Therapy Head @ (September 2020 - March 2022)
- Executive Medical Director, ImmunoOncology and Cell Therapies Research and Development @ Takeda Pharmaceuticals International Co. (October 2017 - September 2020)
- Senior Global Clinical Leader Oncology @ (January 2016 - October 2017)
- Scientific Officer, Clinical R and D @ (January 2014 - January 2016)
- Global Program Medical Director @ (January 2014 - January 2015)
- Professor of Medicine and Director, Stem Cell Transplantation @ (June 2010 - October 2013)
- Associate Professor of Medicine @ (December 1998 - May 2010)
- Assistant Professor of Medicine @ (July 1988 - November 1997)
Mary Laughlin Education
- University at Buffalo
MD (Medicine)
1984-1988 - University of Rochester
Bachelor of Science (Nursing)
1972-1976
Mary Laughlin Skills
- Hematologic Malignancies
- Cross-functional Team Leadership
- Drug Development
- Oncology Clinical Research
- EMA
- Stem Cells
- Leukemia
- Immunology
- Cell
- Cancer
- Cell Based Assays
- Cancer Research
- Medical Research
- Cell Biology
- Hematology
- Tissue Culture
- Flow Cytometry
- Clinical Trials
- Translational Research
- Molecular Biology
- Animal Models
- Assay Development
- Biochemistry
- Biotechnology
- Cancer Immunotherapy
- Cell Culture
- Cell Signaling
- Cell Therapy
- Clinical Development
- Clinical Research
- DNA
- Drug Discovery
- FDA
- Fluorescence Microscopy
- Genetics
- Genomics
- Healthcare
- Immunofluorescence
- Immunohistochemistry
- Laboratory
- Medicine
- Oncology
- RT-PCR
- Regenerative Medicine
- Stem Cell Transplant
- Transplant
- qPCR
- Histology
- Western Blotting
- Neuroscience
- PCR
- Lifesciences
- In Vitro
- In Vivo
- ELISA
- Sales
- PowerPoint
- Strategy
- Rt Pcr
- Microsoft Office
- Leadership
Mary Laughlin Summary
- Mary Laughlin, based in New Providence, NJ, US, is currently a Vice President, Clinical Science at Iovance Biotherapeutics, Inc.. Mary Laughlin brings experience from previous roles at Cleveland Cord Blood Center, ADC Therapeutics, Regeneron and Bristol Myers Squibb. Mary Laughlin holds a 1984 - 1988 MD in Medicine @ University at Buffalo. With a robust skill set that includes Hematologic Malignancies, Cross-functional Team Leadership, Drug Development, Oncology Clinical Research, EMA and more. Mary Laughlin has 4 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mary Laughlin?
Find contact details for 700 million professionals.
Others Named Mary Laughlin
Mary Laughlin
Pediatric Anesthesiologist
California, United States
Top Iovance Biotherapeutics, Inc. Employees
Stephen MacRides
Senior Vice President Global Supply Chain and Logistics
West Chester, PA, US
Howard Johnson
Chief Business Officer
San Carlos, CA, US
Mary Laughlin
Vice President, Clinical Science
New Providence, NJ, US
Kevin Smyth
Executive Vice President, Quality
Kirkland, WA, US
Abel Valdez
Vice President of Sales
Dallas, TX, US
Christine Relay
Vice President, Commercial Strategy
New York, NY, US
Reagan Klima
Vice President, Market Access and Policy
Charleston, SC, US
Michele Fernandes
SVP Portfolio Management
California, United States
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co